Health Care & Life Sciences » Biotechnology | ReNeuron Group PLC

ReNeuron Group PLC

ReNeuron Group PLC
Stock Exchange London Stock Exchange
Market Cap
GBP73.15 M
Shares Outstanding
31.8 M
Public Float
30.53 M


Pencoed Business Park
Pencoed BJ CF35 5HY
United Kingdom
Employees -
Updated 07/08/2019
ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.


View All

Olav Hellebø
Chief Executive Officer & Executive Director
Michael Elliot Hunt
CFO, Secretary & Executive Director